NEWS
Givaudan to acquire Spanish fragrance house Eurofragance
Swiss personal care ingredient maker and fragrance house Givaudan is to acquire a majority stake in Spanish counterpart Eurofragance. The terms of the deal will not
be disclosed but Eurofragance’s business would have represented approximately 185m Swiss francs ($235m) of incremental sales to Givaudan’s results in 2025. Based in Barcelona, Eurofragance
is a family-founded fragrance house specialising exclusively in the design and production of fine fragrances, as well as fragrances for personal and home care. With a strong presence across
Europe, the Middle East, Asia, Africa, and Latin America, the company focuses on high growth regional markets. “Renowned for its agility, creativity, and deep market
The acquisition, which is subject
to regulatory approval, marks an important milestone in Givaudan’s 2030 strategy, aiming to expand its presence and capabilities across local and regional markets to drive sustained business growth. Maurizio Volpi, Givaudan
understanding, Eurofragance combines a perfumery boutique approach with the latest innovations to deliver distinctive olfactive solutions and fragrances tailored to consumer preferences,” said a Givaudan spokeswoman. “By combining Eurofragance’s
entrepreneurial spirit and strong regional footprint with Givaudan’s global leadership and capabilities, the collaboration will enable both companies to bring unique, locally relevant fragrance experiences to consumers worldwide,” she added.
President Fragrance & Beauty, said: “Eurofragance is a respected player with deep roots in fine fragrances and strong relationships in high growth markets. “By joining forces, we are
perfectly aligned with our 2030 strategy for growth and our mission to continue shaping the future of fine fragrance creation.” Santiago Sabatés, chairman
of Eurofragance, said: “We are confident that partnering with Givaudan opens a new chapter for Eurofragance.”
Ingredion makes $5 billion cash play for UK’s Tate & Lyle
US ingredient maker Ingredion is to acquire British counterpart Tate & Lyle for around £3.7 billion ($5 billion) in cash. The Westchester, Illinois firm
will pay £0.595 per share for 100% of Tate & Lyle equity with investors entitled to receive up to an additional £0.20 per share in dividends. Completion of the acquisition
is expected to take place in the second half of 2027. Tate & Lyle is one of the oldest
listed companies in the UK, starting off as a sugar refiner in the late 19th century before focusing on alternative ingredients. In 2024, Tate & Lyle bought CP Kelco, a leader in speciality
gums and pectins, for $1.8 billion to boost its products that improve food texture. Ingredion said the acquisition
broadens its speciality ingredients platform across texturants, sugar reduction, and fortification, adding complementary capabilities in multi-ingredient systems and recipe development. “Combining Ingredion and Tate
& Lyle’s complementary portfolios establishes a global leader in ingredient solutions with the innovation expertise and geographic reach that will help create the future of food,” said Jim Zallie, chairman, president and CEO of Ingredion. “The combined business will be better positioned to serve customers’
9
Syensqo launches strategic review
of care segment Syensqo has initiated a strategic review of its Performance & Care segment, which includes beauty and home care. The Belgian company said the
review is in line with its intention to focus on becoming a pure play speciality materials and advanced technologies company, with greater exposure to aerospace and defence, electronics, healthcare, energy and advanced mobility applications. Syensqo’s Performance & Care
segment, comprising the Novecare and Technology Solutions global business units, serves the consumer care, agro, coatings and mining end markets. In 2025, the segment generated
net sales of €2 billion ($2.33 billion) and an underlying EBITDA of €358m. “Since the start of the year,
and along with the board, we have undertaken a strategic assessment of our long-term direction and value creation priorities, said CEO Mike Radossich. “In addition, we are fully
focused on accelerating our growth trajectory, driving more consistent execution, sharpening our capital discipline as well as improving cash flow delivery,” he added. “Today’s announcement reflects
needs for the development of great-tasting, healthier and affordable food products that consumers demand,” he added. David Hearn, chair of Tate &
Lyle said: “Over the last few years, Tate & Lyle has been successfully repositioned as a leading global speciality food and beverage solutions business aligned to growing consumer demand for healthier, more nutritious and sustainable food and drink.
our intention to further sharpen our portfolio, increase our focus on technologies where we see the strongest long-term growth opportunities and drive sustained, innovation-led differentiation.” Radossich continued:
“Accordingly, we will now evaluate a range of strategic options for the Performance & Care segment, with an emphasis on maximizing long- term value for our shareholders.” Syensqo has not set a defined
timetable for the strategic review, and will provide further updates when appropriate.
P2 Science secures $23m funding to expand ingredient portfolio
US ingredient maker P2 Science has closed a $23m funding round to expand its beauty and personal care portfolio and entry into performance polymers, home care, coatings, and crop care. The Woodbridge, Connecticut
company attracted new investors Emerald Technology Ventures and
www.personalcaremagazine.com
GS Futures, who joined the round alongside existing backers including Lewis & Clark Partners, DSM- Firmenich, Connecticut Innovations, Elm Street Ventures, Chanel, BASF, and Safer Made.
P2 said the participation from
both new and returning partners reflects growing confidence in
its commercial traction, proven innovation leadership, and the scalability of its green chemistry platform.
“This milestone validates the
strength of our technology and the urgency of global demand for clean, scalable manufacturing solutions,” said CEO Oihana Elizalde.
“With this new funding, we
are positioned to supercharge our beauty business and bring real green chemistry solutions to entirely new industries,” she added. The funding round was led by
Sofinnova Partners, a European life sciences venture capital firm with offices in Paris, London and Milan.
July 2026 PERSONAL CARE MAGAZINE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
